Physician profile
Karsten H Fliegner
NPI 1932211398
$1,719.95
in general payments reported to CMS, 2019-2025
13 companies · $714 in 2025
The $714 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $94.26 · 2021: $30.92 · 2022: $164 · 2023: $106 · 2024: $188 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $477.90 | 2025 | Rapiblyk |
| Edwards Lifesciences Corporation | $439.71 | 2019-2022 | |
| Medtronic, INC. | $287.78 | 2023-2025 | Signia, Avalus, Penditure |
| Medtronic Vascular, INC. | $124.99 | 2019 | |
| Atricure, INC. | $86.32 | 2023-2025 | Synergy Ablation System |
| Abbott Laboratories | $79.40 | 2020 | |
| Baxter Healthcare | $76.41 | 2021-2025 | Preveleak |
| Organogenesis INC. | $38.14 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.56 | 2025 | Lifevest |
| Getinge USA Sales, LLC | $24.83 | 2023 | Vasoview Hemopro 2 |
| Actelion Pharmaceuticals US, INC. | $22.36 | 2019 | |
| Pinnacle, INC | $21.69 | 2025 | |
| Davol INC. | $14.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karsten Fliegner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.